ApproachServicesAboutContact
Emerging Pharma Commercialization

Critical Insights.
Critical Decisions.

We help emerging pharmaceutical companies get to market — and grow once they're there — with comprehensive commercialization strategy and the technology to execute it. Focused senior attention. Deep pharma expertise. Without Big Pharma pricing.

Full
Lifecycle coverage: pre-launch → launch → post-launch
Strategy
Before tools. Always.
60%
of drug launches underperform — strategy closes the gap
1st
Launch is our specialty — built for first-launch teams
Our Approach

Three phases. One roadmap.

Every engagement follows a disciplined arc — because even great drugs fail without execution.

PHASE 01

Assess

Market and readiness assessment: landscape analysis, payer and access environment, commercial strategy evaluation, and a readiness baseline you can act on.

PHASE 02

Plan

Integrated strategy and execution planning: brand and access strategy, pricing and trade planning, field design, commercial operations, and cross-functional orchestration with clear milestones.

PHASE 03

Optimize

Post-launch performance optimization: analytics dashboards, commercial data management, targeting refinement, and digital transformation tuned to real-world data.

Services

Four practices. Strategy before tools — always.

Technology enables the strategy; it never drives it. Each practice stands alone and connects into a single commercialization roadmap.

Commercial Strategy & Planning

Launch and post-launch commercial strategy — brand planning, market assessment, and forecasting for emerging pharma.

  • Launch & post-launch strategy
  • Brand & indication planning
  • Market assessment & forecasting

Access Strategy

Reimbursement, pricing, trade, patient strategy, and payer engagement — comprehensive market access strategy from pre-launch through commercialization.

  • Reimbursement & pricing strategy
  • Trade & channel strategy
  • Patient strategy & payer engagement

Commercial Operations

National and subnational commercial operations supporting executive-level decisions and field strategy and execution.

  • Executive-level analytics
  • Field strategy & execution
  • Subnational targeting & territories

Digital Transformation

Commercial data analysis and business rules development in support of strategic initiatives and commercial data management.

  • Commercial data analysis
  • Business rules development
  • Data management & strategic initiatives

Where do you start?

With a fixed-scope commercialization readiness assessment — fast turnaround, clear roadmap.

About Us

Emerging pharma is our whole business.

Not a Big 5 firm. Not generalists. Critical Insights was built for emerging pharma — dedicated senior attention, deep commercial expertise, and technology that serves the plan.

Mathew Linkewich
Managing Partner, Strategy
Robert Polans
Managing Partner
Access
Richard Ciorra
Managing Partner, Commercial Operations
Kiran Mansukhani
Managing Partner, Technology
Why Us

Emerging-pharma focus

Every client gets dedicated senior attention — never a bench of juniors.

Deep pharma expertise

We live in commercial pharma every day — not generalist consulting.

Strategy before tools

Technology serves the strategic plan, never the reverse.

Built for emerging pharma

Affordable, agile, and experienced with first-product launches.

Contact

Let's get you to market.

Tell us where you are in the commercialization journey — we'll show you what strategy-first support looks like.

Opens your email client. We'll respond within 2 business days.

v20260903-1849